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Abstract
Complexity analysis of glucose time series with Detrended Fluctuation Analysis (DFA) has
been proved to be useful for the prediction of type 2 diabetes mellitus (T2DM) development.
We propose a modified DFA algorithm, review some of its characteristics and compare it
with other metrics derived from continuous glucose monitorization in this setting. Several
issues of the DFA algorithm were evaluated: (1) Time windowing: the best predictive value
was obtained including all time-windows from 15 minutes to 24 hours. (2) Influence of circa-
dian rhythms: for 48-hour glucometries, DFA alpha scaling exponent was calculated on 24-
hour sliding segments (1-hour gap, 23-hour overlap), with a median coefficient of variation
of 3.2%, which suggests that analysing time series of at least 24-hour length avoids the influ-
ence of circadian rhythms. (3) Influence of pretreatment of the time series through integra-
tion: DFA without integration was more sensitive to the introduction of white noise and it
showed significant predictive power to forecast the development of T2DM, while the pre-
treated time series did not. (4) Robustness of an interpolation algorithm for missing values:
The modified DFA algorithm evaluates the percentage of missing values in a time series.
Establishing a 2% error threshold, we estimated the number and length of missing segments
that could be admitted to consider a time series as suitable for DFA analysis. For compari-
son with other metrics, a Principal Component Analysis was performed and the results
neatly tease out four different components. The first vector carries information concerned
with variability, the second represents mainly DFA alpha exponent, while the third and fourth
vectors carry essentially information related to the two “pre-diabetic behaviours” (impaired
fasting glucose and impaired glucose tolerance). The scaling exponent obtained with the
modified DFA algorithm proposed has significant predictive power for the development of
T2DM in a high-risk population compared with other variability metrics or with the standard
DFA algorithm.
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Introduction
Many biological systems display a complex behaviour, and often one of the earliest signs of dis-
ease or senescence is the loss of complexity in its output [1–3]. This phenomenon may precede
the first clinical signs and may have important prognostic implications.
The glucoregulatory system is a clear example. Glucose blood levels need to be tightly con-
trolled while the patient operates in very different conditions. In the fasting status, hepatic glu-
cose production is the main source of glucose available. On the other hand, in the postprandial
state, the patient must handle an important glucose overload by using it as metabolic fuel or by
storing it as glycogen. This balance is reached through a complex network of hormones with
both feedback and feed–forward loops, and thus a potentially ideal field to explore complexity
metrics.
During the last decades, T2DM (type 2 diabetes mellitus) has become a growing epidemic
due to the rising prevalence of obesity as a consequence of the Western lifestyle, and is respon-
sible for significant morbi–mortality among high–risk populations [4]. Nevertheless, consider-
ing T2DM as a disease derived only from high plasma glucose levels is an oversimplification:
glucose oscillations may have adverse effects, independently of the raw glycaemic levels, and
indeed glycaemic variability was shown to be a risk factor for glycaemic complications [5, 6].
The route from health to T2DM is a continuum that typically follows one of two possible
paths. Some patients are able to maintain normal glycaemia during fasting but are unable to
handle the glucose overloads induced by eating (impaired glucose tolerance), while other
patients can handle these overloads, but are unable to lower their basal glycaemia to normal
levels during fasting (impaired fasting glucose) [7]. Both mechanisms eventually merge
together and coexist in full–blown T2DM. As the glucoregulatory dysfunction evolves, there is
a progressive loss of the pancreatic beta–cell (responsible for the insulin secretion) and the risk
of developing clinical complications gradually increases [8]. For clinical purposes, glycaemic
thresholds have been established in order to classify patients by stages. Nevertheless, these
thresholds are somehow arbitrary, and by the time a diagnosis of T2DM is made, 50% of beta–
cell function has been lost [9, 10], patients have already developed end–organ damage and are
at increased risk for cardiovascular disease [8, 11].
In the last years, the introduction of Continuous Glucose Monitoring Systems (CGMS) that
allow for prolonged, high–frequency, innocuous assessment of interstitial glucose, has fuelled
the development of new metrics to monitor glucose dynamics [12–16].
There is no general consensus on how to analyse glucose time series. Probably the most
generalized metrics are just a distribution description (range, standard deviation, coefficient of
variation). However, while simple and straightforward, these metrics have several drawbacks,
the most important of them being the assumption of independence of points, and therefore
omitting a crucial aspect of a time series: namely its sequentiality. Other metrics (Mean Ampli-
tude of Glycaemic Excursion (MAGE) [17], Continuous Overall Net Glycaemic Action 2 hour
(CONGA-2) [18], etc.) take into account the sequentiality but depend heavily on some arbi-
trary thresholds.
Complexity analysis seems an excellent tool to analyse glucose time series, and among the
several possible approaches, DFA [19] is arguably the most frequently used. DFA alpha scaling
exponent is higher (lower complexity) in type 1 diabetics than in healthy patients [20], and
also increases as patients walk their path from health, through prediabetes to full–blown
T2DM [2]. Furthermore, this metric may help predicting the risk of development of T2DM in
at-risk populations [21].
The main idea underlying DFA is to analyse how the informational content of a time series
is distributed throughout the different time–windows. A complex time series will have
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proportionally more information encoded in small time–windows. As the system decays, its
ability to detect and react to minor changes is blunted, and thus the informational content of
small time–windows decreases. This is manifested as an increase in DFA scaling exponent,
that is, a decrease in its complexity.
In the present paper we propose a customization of the standard DFA algorithm for diabe-
tes risk forecasting to achieve a significant classification capability. We review some of its char-
acteristics and compare the performance of the simplified DFA algorithm with that of several
other CGMS’ derived metrics [22], including other complexity statistics such as Approximate
Entropy (ApEn) [23], Sample Entropy (SampEn) [24], or Poincaré plots [25]. To evaluate the
performance of the complexity metrics we assessed their power to predict the evolution to
T2DM in a population of patients with essential hypertension, a condition known to be a risk
factor for T2DM development [26].
Materials and methods
Patients data set
The data set has already been published by our group [21]. Essentially, there were 208 patients
selected from the outpatient clinic of hypertension and vascular risk of the University Hospital
of Móstoles, in Madrid, from January 2012 to May 2015. The inclusion criteria were: age
greater than 18 and lower than 85 years, a previous diagnosis of essential hypertension and the
exclusion of a previous diagnosis of diabetes mellitus or treatment with antidiabetic drugs. The
original study was approved by the Hospital’s Ethical Committee and a written informed con-
sent was obtained from each patient before inclusion. A CGMS (iPro, MiniMed, Northridge,
CA, USA) record was obtained at inclusion, for at least 24h with sampling every 5’. Patients
were then followed every 6 months until the diagnosis of T2DM or end of study. A diagnosis
of T2DM was established with either basal glucose tests� 126mg/dl, and/or haemoglobin A1c
test� 6.5%, both confirmed in a second measurement. The median follow–up was 33 months
(range: 6 to 72 months). There were 17 new cases of T2DM, with a median time to diagnosis
of 33.8 months (IQR 24.1). Details may be found in Table 1.
DFA algorithm
The DFA script is based on the description in [19] and is written in R. It is publicly available at
the journal’s site.
The input is a vector with at least 288 values (assuming a glucose measurement every 5’ dur-
ing at least 24 hours), with no missing values at the beginning or the end of the series. Missing
values are allowed along the series, and are handled as described later. If the time series has
more than 288 values, the script goes through the whole time series, analysing every 24h seg-
ment with a 1h step (and 23h overlap) (e.g.: day 1: 08.00 to day 2: 08.00; day 1: 09.00 to day 2:
09.00, etc). Finally, the algorithm returns the sweeping average of DFA alpha exponent. The
essential steps are:
• Missing values are repaired through linear interpolation [27]. In order to handle their
weight, a shadow variable is created, stating which values are real measurements and which
are interpolated. A tolerance threshold is established (by default, 0.2).
• The windowing is set to 3, 4, 6, 8, 9, 12, 16, 18, 24, 32, 36, 48, 72, 96, 144 and 288 points (all
exact divisors of 288), and corresponding to time windows of 15’, 20’, 30’, 40’, 45’, 1h, 1h20’,
1.5h, 2h, 2h40’, 3h, 4h, 6h, 8h, 12h and 24h.
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• For each time frame, the series is divided in segments, and a linear regression is calculated











where F(n) measures the difference between the time series and the regression line, N is the
total number of data points, y(k) is the value of the pre–processed time series y at point k
and yn(k) is the value of the regression line at that point. For each segment, the script evalu-
ates if the number of interpolated values is greater than the tolerance threshold. If this is the
case, that segment’s result is substituted by the mean of the segments of the same window
length.
• This process is repeated for all time–window sizes, obtaining as many F(n) as time–window
sizes.
• A linear regression model is fitted between log(F(n)) and log(window size). If the model fits
correctly (p< 0.001), the alpha scaling exponent is obtained as the slope of the regression
model; otherwise, a warning appears.




Follow up (months) 33.1 19.2
BMI(Kg/m2) 29.3 5.4
Basal glycaemia (mg/dL)� 100.6 11.4
HbA1c(%) 5.8 0.4
Coefficient of variation 0.15 0.08
CONGA-2 19.11 11.8
MAGE(mg/dL) 39.5 21.9









IQR: interquartile range; BMI: body mass index; HbA1c: haemoglobin A1c; CONGA2: Continuous Overall Net
Glycaemic Action 2 hour; MAGE: Mean Amplitude of Glycaemic Excursions; FI: Fluctuation Index; TU100: Time
under the 100 mg/dl glycaemic threshold; AO140: Area over the 140 mg/dl glycaemic threshold; ApEn: Approximate
Entropy; SampEn: Sample Entropy; DFA: Detrended Fluctuation Analysis α exponent; Poincaré–SD1: Standard
deviation of points in the width axis of an ellipse fitted to a Poincare plot; Poincaré–SD2: Standard deviation of
points in the length axis of an ellipse fitted to a Poincaré plot; Poincaré–E: Eccentricity of the ellipse (SD2/SD1).
� Variables with normal distribution are expressed as mean and standard deviation.
https://doi.org/10.1371/journal.pone.0225817.t001
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Windowing. To analyse the influence of the different windowing sets on DFA alpha’s
predictive power, a vector with all the exact divisors of 288 was built. Every possible set of con-
tinuous time windows were tested, with a minimal window ranging from 15 minutes to 90
minutes and a maximal window ranging from 4 hours to 24 hours. With each of these win-
dowing sets we calculated the alpha exponent value of the patients included in the data set, and
evaluated its efficiency in predicting the development of T2DM. This was assessed by means of
a Cox proportional hazard model (survival R package).
Coefficient of variation. In the cases when time series longer than 24h were available, a
test was performed in order to explore the influence of the starting time of the 24 hour record.
From 208 patients, 191 patients had a 48 hour CGMS record. In these patients, the alpha scal-
ing exponent was calculated in sweeping 24h long segments, with 1h steps (and 23h overlap).
A coefficient of variation was obtained for each patient.
Pre–treatment through integration. Most publications using DFA in diabetes treat the






where xi is the value of the original time series x at point i. This ensures a brownian dynamic,
allowing its inclusion in a random walk model, and standardizes the meaning of its results (e.g,
α> 1.5: positive correlation, α< 1.5: negative correlation). Furthermore, this preprocessing
smoothens the time series profile and solves the missing–values problem. However, this may
significantly affect DFA’s sensitivity. In the present work, we propose to skip the pre–process-
ing of the time series and proceed to the DFA calculation on the raw data, that is, y = x.
To provide a better support to our decision of not integrating the time series, we applied a
method to ensure our CGM records could be considered as fractional Brownian motion (fBm)
[28, 29].
To compare both methods (DFA with and without pre–treatment) we calculated both met-
rics in all our patients, and used both results in two different tests:
• Influence of white noise. Each of the first 24h of all the 208 time series included in the patient
database were evaluated. From each time series, 15 replicas were created, with an increasing
addition of random noise (uniform distribution with average 0 and range increasing from
-1:+1 mg/dl to -15:+15 mg/dl). From each of the replicas, an integrated series was obtained
following the above-mentioned algorithm. The two DFA metrics were calculated for each
time series and were plotted against the intensity of the random component. A linear corre-
lation model was fitted between the alpha exponent and range (random component), and
the slope of the changes in both DFAs were compared.
• Predictive power. We compared the predictive power of the integrated time series vs. the
non–integrated series in a Cox proportional hazard model [30] to forecast the development
of full–blown T2DM.
Except for the sections dealing with the influence of pre–treatment through integration, all
other alpha exponent results and figures referred in this manuscript were obtained omitting
the aforementioned pre–treatment. For comparisons, henceforward DFAint and DFAraw are
used to refer to DFA with or without integration, respectively.
Robustness of the interpolation algorithm. As exposed earlier, the DFA algorithm evalu-
ates the percentage of missing (and thus interpolated) values. Although recent technological
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developments are minimizing missing data, this has been a limitation in the clinical context
where conditions cannot be completely supervised.
DFA requires a time series without missing data. The trivial approach to missing values is
interpolation. However, depending on the length and the number of missing segments, this
may have serious effects on DFA results. Therefore, it seemed mandatory to assess the conse-
quences of the length and number of missing (and interpolated) values, and to establish a
threshold above which the time series can not be trustfully analysed. In order to do this, 30
time series with no missing values were selected. In each time series, 540 replicas were created
and:
• A set of n segments of length l were deleted (and interpolated). The length of the omitted
segments varied between 4 elements (20’) to 30 elements (150’) and the number of segments
varied between 1 and 20 (or half the length of the time series, whatever happened before).
• The precise location of the missing segments was random, and the process was repeated 30
times for each time series.
• The mean absolute difference between the interpolated time series and the original series
was evaluated for each combination of n (number of missing segments) and l (length of the
missing segments).
• This process was repeated for all 30 patients, and a mean absolute error was calculated for
each combination of n and l of the complete set of patients.
Comparison of different metrics
We compared the efficiency (in predicting the risk of T2DM in a Cox proportional hazard
model) of several of the most frequent CGMS variability metrics. An exhaustive discussion of
each metric is out of the scope of this paper, but schematically:
1. Conventional variability metrics: coefficient of variation (standard deviation/mean).
2. Variability metrics considering sequentiality:
• CONGA-2 [18] is the standard deviation (sd) of the range of differences in glycaemia
between points separated by 120 min.
• MAGE [17]. A glycaemic excursion was defined as a excursion greater than 1 SD of the
time series.
• Glycaemic Fluctuation Index [31]. The area between the glycaemic profile and the mean
glycaemia.
3. Metrics related with prediabetic phenotype:
• Time under the 100 mg/dl glycaemic threshold (TU100). Generally, the Impaired Fasting
Glucose (IFG) phenotype is defined as a categorical variable (fasting glycaemia > 100mg/
dl). However, transforming it into a quantitative variable may drastically change its sensi-
tivity [32], so the percentage of time with glycaemia lower than 100 mg/dL has been mea-
sured as an indicator of fine fasting glucose control.
• Area over the 140 mg/dl glycaemic threshold (AO140). Similarly, the Impaired Glucose
Tolerance (IGT) phenotype is usually employed as a qualitative variable (glycaemia� 140
mg/dL and< 200 mg/dL, 2 hours after 75-gr glucose overload). Again, transforming it
DFA model optimization for type 2 diabetes mellitus prediction
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into a quantitative variable (area above 140 mg/dl threshold) greatly increases its predictive
value [32].
4. Entropy-related estimations. In essence, these metrics assess the predictability of the time
series, evaluating to what extent the preceding points determine the following values. This
is performed analysing the frequency of repeated patterns. Higher ApEn or SampEn, there-
fore less predictability, implies higher complexity:
• ApEn [23].
• SampEn [24].
5. Metrics derived from the Poincaré plot [33]. A plot is created with glycaemia at point
(i) in the horizontal axis vs. glycaemia at point (i + 1) (delay map). The resulting cloud of
points is fitted to an ellipse:
• Standard deviation of the points on a delay map with respect to the horizontal axis (width)
of the fitted ellipse (SD1).
• Standard deviation of the points on a delay map with respect to the vertical axis (length) of
the fitted ellipse (SD2).
• Eccentricity of the fitted ellipse (E): SD2/SD1
6. DFAraw, as previously described.
ApEn and SampEn were calculated by means of the pracma R package. All other scripts
were directly written in R. Among the various metrics with statistically significant predictive
power, a Principal Component Analysis (PCA) (psych R package) was performed in order to
assess how these metrics correlated with one another. In PCA, it is conventional to select only
those factors with eigenvalues greater than 1, as an eigenvalue of 1 indicates that a factor can
only explain as much variance as a single item [34]. For this reason, factors were selected if
their eigenvalue was greater than 1.0. A varimax rotation was applied to clarify the structure of
the loading matrix, and the rotated components (RCs) were used instead of the original princi-
pal components (PCs) since they provide a more intuitive interpretation of the results.
Statistics
Variables are expressed as mean and standard deviation (SD) if they have a normal distribu-
tion, and as median and interquartile range (IQR) otherwise. All statistics were performed
with R (https://www.r-project.org). Significance was assumed when 2–tail p< 0.05 (except for
the log(Fn)–log(window) correlation in DFA algorithm, in which, this being a log–log correla-
tion, a p< 0.001 was required).
Results and discussion
In the present work we introduce several variations of the DFA algorithm that could provide
some advantages regarding its applicability in the clinical field. Moreover, we test its accuracy
on a practical scenario by correlating its results with proportional risk of T2DM development
in a high risk population in real–life conditions, followed up for a period of time.
DFA windowing
Among all the windowing sets evaluated, the best predictive value for T2DM development was
obtained with the set that included all time-windows from 15’ to 24h (15’, 20’, 30’, 40’, 45’, 1h,
DFA model optimization for type 2 diabetes mellitus prediction
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1h20’, 1.5h, 2h, 2h40’, 3h, 4h, 6h, 8h, 12h and 24h), with a Cox coefficient of 8.344(p = 0.027).
A 0.1 increase in DFAraw alpha scaling exponent results in 2.3 odds ratio of T2DM. Other sets
of windowing (e.g. from 20 minutes to 24 hours; from 15 minutes to 12 hours) provided
smaller Cox coefficients and therefore they do not seem to offer any advantage. Fig 1 displays
two heatmaps with the Cox coefficient for different windowings and the p-values of the Cox
model.
Coefficient of variation
As explained before, DFA alpha exponent was calculated on sliding 24-hour segments with
1-hour steps for those series longer than 24 hours, and a coefficient of variation was obtained
for the values of each patient. The median coefficient of variation was 3.2%, with an interquar-
tile range of 2.2%. Our data show no significant differences in alpha values between different
segments of 24 hours time series taken at different day-times. It has been well-established that
there is a level of regulation based on circadian rhythms beyond sleeping patterns and meals.
Many researchers have underlined that the plasmatic glucose rhythm may be influenced by
hormones whose secretion is narrowly related to day–night rhythm (such as cortisol, growth-
hormone, etc. [35, 36]). However, our results suggest that analysing time series of at least 24h
avoids the influence of circadian rhythms and thus the results are not significantly interfered
by the day–time in which the CGMS is implanted.
Pretreatment through integration
Although most authors using DFA in diabetes integrate time series before detrending, this is
not universally accepted, and some authors have applied DFA without pre-integration [37].
Despite the extended practice, we feel that this pre–processing may have a great cost in
sensitivity.
The power spectra of all the time series was computed, and a non-linear y = α � xβ power
curve was fitted (p< 0.01 in all cases) to the frequency domain data in order to estimate
the exponent β. Averaging all the results obtained, the exponent value achieved was
β = −8.144719 + / − 0.5175, which is clearly in accordance with the fBm assumption, and
therefore we assumed that integration could be omitted [28].
Fig 1. Predictive power of DFA alpha scaling exponent to forecast the development of T2DM on Cox survival analysis. (A)
Heatmap with Cox proportional hazard coefficient for different windowings. (B) Cox coefficient’s p-value for different windowings.
https://doi.org/10.1371/journal.pone.0225817.g001
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To evaluate the influence of pretreatment through integration before proceeding to
detrending, two tests were performed:
• Influence of a random component (white noise). Considering that white noise has α = 0.5,
we assumed (and empirically confirmed) that introducing white noise in the time series
would reduce its alpha exponent. In order to determine to what extend alpha value is altered
by white noise, each time series was exposed to a random component as explained in the
Material and Methods section, to create several replicas of the series and alpha exponent was
measured in each replica, both with and without pre–treatment through integration. The
rate of decline was significantly steeper in non-integrated than in integrated series (-0.042
(SD: 0.0033) vs. -0.023 (SD 0.0053); p< 0.001). Fig 2 displays the evolution of DFAraw and
DFAint as the intensity of the random component increased.
More formally, a General Linear Model was built with DFA alpha exponent as the dependent
variable and the intensity of the random component and pre–treatment through integration
(qualitative: yes/no) as independent variables. As expected, both variables were statistically
significant (integration: coef. = 0.627, p< 0.01; randomness: coef. = −0.041, p< 0.019) but
notably so was their interaction (coef. = 0.016, p< 0.01). This data show an earlier and
steeper drop of alpha as the random component increases in the non-integrated time series
compared to the pre-treated time series. This suggests a decrease in sensitivity attributable to
the pre–treatment through integration.
• Predictive power. As stated previously, in the non–integrated time–series, several window-
ing sets produced significant predictions, with a maximum Cox coefficient of 8.344
Fig 2. Influence of integration on DFA alpha scaling exponent values. (A) Rate of decline of alpha with the addition of an
increasing component of randomness (white noise) in series pre–treated through integration (DFAint) or not (DFAraw). (B)
Boxplot of the differences of the alpha exponent values between both methods.
https://doi.org/10.1371/journal.pone.0225817.g002
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(p = 0.027). In contradistinction, no set of windowings was able to produce a significant Cox
model with the integrated time–series.
To summarise, our data suggest that omitting integration and thus stepping out of the ran-
dom walk model increases alpha’s sensitivity and may arguably boost its clinical efficiency. Of
course, the standard 1.5 threshold loses its meaning, but DFA remains a useful tool to explore
how the informational content of a time series is distributed throughout its time–windows,
and may be employed to compare different glycaemic profiles.
Robustness of the interpolation algorithm
To explore the influence of missing (and interpolated) values on the scaling exponent
calculations (i.e. to evaluate the robustness of the DFA algorithm in handling lost measure-
ments), we deleted an increasing number of randomly distributed segments of increasing
length and assessed the resulting error (compared with the complete series), as exposed
above.
Fig 3 is a heat–map representing the error (as %) depending on the number and length of
missing segments. We fixed a threshold of 2% error to consider a time series as suitable for
DFA analysis. With this limit, we propose an admission criteria for a time series to be subjected
to DFA: schematically, a time series should be rejected if ever the missing segments surpassed:
twenty times a 20’ segment, or eleven 30’, or six 45’, or four 1h, or one 1.5h, or any longer than
1.5h missing segments. To ensure compliance, we suggest counting the number of missing seg-
ments and establishing the length of the largest missing segment.
Comparison of different metrics
Several CGMS–related metrics (described above) were applied to the first 24h series of all
patients, and their results were included as independent variables in a univariate Cox propor-
tional hazard model to assess the risk of T2DM development. Results of this analyis are dis-
played in Table 2. Only CONGA2, MAGE, TU100, AO140, Poincaré–SD1, Poincaré–SD2 and
DFAraw alpha exponent were significant predictors.
To analyse how these variables related with one another, we performed a PCA with varimax
rotation as referred in Material and Methods. Table 3 presents the resulting model. Four prin-
cipal components were selected, carrying 96% of the variance. The results neatly tease out four
different elements. The first vector (RC1) carries information concerned with variability. The
vector carrying the second largest amount of variance (RC3) represents mainly DFAraw scal-
ing exponent, while the third and fourth vector carry essentially the information related with
the two pre–diabetic behaviours (impaired fasting glucose in the third vector, RC4, and
impaired glucose tolerance in the fourth vector, RC2).
The prompt separation of variability metrics (first vector) and DFA scaling exponent (sec-
ond vector) probably reveals that, although in several studies [2, 21, 32] variability and com-
plexity show a strong inverse correlation, they explore different phenomena. Arguably,
variability metrics deal with short–term fluctuations, and are less sensitive to long–term corre-
lations. Instead, DFA explores this issue analysing the correlation behaviour as the time win-
dow is modified, and thus exploring the informational content all along different time–
grainings. It seems reasonable to expect that physiologic systems based on complex hormonal
loops (sometimes requiring sensing, protein synthesis, transportation and distant action)
should need a wide variety of time–windows to be fully explored.
DFA model optimization for type 2 diabetes mellitus prediction
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Fig 3. Error depending on the number and length of missing segments. Each unit of missing segment represents 5
minutes. In 30 series originally with no missing values, an increasing number of randomly distributed segments of
increasing length were deleted and interpolated. The process was repeated 30 times for each combination of length and
number of deleted segments and for each patient, and DFA scaling exponent was calculated for each replica. The mean
error (absolute difference with the real alpha value (complete series)) was recorded for each combination of length and
number of missing segments.
https://doi.org/10.1371/journal.pone.0225817.g003
Table 2. Cox proportional hazard model for different metrics.
Metric Cox coefficient p
Coefficient of variation 2.679 0.499
CONGA-2 0.061 0.004
MAGE(mg/dL) 0.019 0.003
Fluctuation index 0.082 0.065
TU100(%) -3.05 0.004
AO140 0.0006 < 0.001
ApEn -2.671 0.341
SampEn -0.767 0.741
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Conclusions
We propose and analyse a DFA algorithm that omits pre–treatment through integration and
manages missing (and interpolated) data considering their weight in each time window. This
algorithm has significant predictive power as for the development of T2DM in a high–risk
population. Furthermore, this metric explores dynamical aspects of the time series not dis-
played by other variability metrics.
Omitting pretreatment through integration improved substantially the predictive power of
DFA alpha exponent (best Cox coefficient with optimal windowing: 8.32, p = 0.03), while no
set of time-windows had significant predictive power with pre-treated time series. We describe
the effect of different number and size of missing segments, and we propose an admission crite-
ria to assure an error les than 2%. Several glycaemia-related metrics are able to predict the
development of T2DM in our population. A principal component analysis on these metrics
neatly teases out four vectors: one grouping variability metrics (CONGA–2, MAGE and Poin-
caré plot–derived variables), another displaying complexity (DFA alpha exponent) and two
other displaying the two polar prediabetic phenotypes (impaired glucose tolerance and
impaired fasting glucose).
DFA alpha scaling exponent (omitting pre–treatment through integration) has significant
predictive power on the development of T2DM in patients at risk, independently of other vari-
ability metrics.
The main limitation of our study is the inability of comparison with most DFA studies due
to our decision to omit pre–treatment through integration. Furthermore, the differences in the
measurements between different glucometers are unknown. For that reason, we believe more
research should be done in order to test this algorithm in different populations, with bigger
samples and different glucometer models.
Supporting information
S1 File. Glucose time series and clinical database. This file includes glucose time series from
all patients included in the study and the database with clinical variables.
(ZIP)
Table 3. Principal Components Analysis of the variables selected in the Cox proportional hazard model.
A RC1 RC3 RC4 RC2
SS loadings 3.09 1.47 1.09 1.05
Proportion of variance 0.44 0.21 0.16 0.15
Cumulative variance 0.44 0.65 0.81 0.96
B RC1 RC3 RC4 RC2
CONGA-2 0.84 0.41 0.26 -0.14
MAGE(mg/dL) 0.80 0.42 0.25 -0.08
TU100(%) -0.14 -0.11 -0.17 0.97
AO140 0.34 0.15 0.90 -0.21
DFAraw α exponent 0.22 0.95 0.12 -0.11
Poincaré–SD1 0.95 -0.09 0.15 -0.15
Poincaré–SD2 0.81 0.42 0.29 -0.07
Loadings greater than 0.8 are highlighted. (A) SS loadings for each of the components. (B) Standardized loadings for
each variable. RC 1–4 refers to each of the rotated (Varimax) components obtained by PCA.
https://doi.org/10.1371/journal.pone.0225817.t003
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patients with essential hypertension. Am J Med. 2006; 119(4):318–326. https://doi.org/10.1016/j.
amjmed.2005.09.010 PMID: 16564774
27. Lepot M, Aubin JB, Clemens FHLR. Interpolation in Time Series: An Introductive Overview of Existing
Methods, Their Performance Criteria and Uncertainty Assessment. Water. 2017; 9(10). https://doi.org/
10.3390/w9100796
28. Eke A, Hermán P, Bassingthwaighte JB, Raymond GM, Percival DB, Cannon M, et al. Physiological
time series: distinguishing fractal noises from motions. Pflugers Arch. 2000; 439:403–415. https://doi.
org/10.1007/s004249900135 PMID: 10678736
DFA model optimization for type 2 diabetes mellitus prediction
PLOS ONE | https://doi.org/10.1371/journal.pone.0225817 December 18, 2019 14 / 15
29. Eke A, Herman P, Kocsis L, Kozak LR. Fractal characterization of complexity in temporal physiological
signals. Physiol Meas. 2002; 23:R1–R38. https://doi.org/10.1088/0967-3334/23/1/201 PMID:
11876246
30. Sedgwick P. Cox proportional hazards regression. BMJ. 2013; 347.
31. King AB, Philis-Tsimikas A, Kilpatrick ES, Langbakke IH, Begtrup K, Vilsbøll T. A Fixed Ratio Combina-
tion of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More
Patients with Type 2 Diabetes Within Blood Glucose Target Ranges. Diabetes Technology & Therapeu-
tics. 2017; 19(4):255–264. https://doi.org/10.1089/dia.2016.0405
32. Colas A, Vigil L, Rodrı́guez de Castro C, Vargas B, Varela M. New insights from continuous glucose
monitoring into the route to diabetes. Diabetes/Metabolism Research and Reviews. 2018; 0(0):e3002.
https://doi.org/10.1002/dmrr.3002
33. Henriques T, Munshi MN, Segal AR, Costa MD, Goldberger AL. “Glucose-at-a-Glance”: New Method to
Visualize the Dynamics of Continuous Glucose Monitoring Data. Journal of Diabetes Science and Tech-
nology. 2014; 8(2):299–306. https://doi.org/10.1177/1932296814524095 PMID: 24876582
34. Hinton PR. 22: Complex Analysis. In: Statistics Explained. Routledge; 2004. p. 306.
35. Cauter EV, Blackman JD, Roland D, Spire JP, Refetoff S, Polonsky KS. Modulation of glucose regula-
tion and insulin secretion by circadian rhythmicity and sleep. The Journal of Clinical Investigation. 1991;
88(3):934–942. https://doi.org/10.1172/JCI115396 PMID: 1885778
36. Qian J, Scheer FAJL. Circadian System and Glucose Metabolism: Implications for Physiology and Dis-
ease. Trends in Endocrinology and Metabolism. 2016; 27(5):282—293. https://doi.org/10.1016/j.tem.
2016.03.005 PMID: 27079518
37. Hwa RC, Ferrée TC. Scaling properties of fluctuations in the human electroencephalogram. Physical
review E, Statistical, nonlinear, and soft matter physics. 2002; 66 2 Pt 1:021901. https://doi.org/10.
1103/PhysRevE.66.021901 PMID: 12241208
DFA model optimization for type 2 diabetes mellitus prediction
PLOS ONE | https://doi.org/10.1371/journal.pone.0225817 December 18, 2019 15 / 15
